BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119-130. [PMID: 28447000 DOI: 10.21037/acs.2017.03.14] [Cited by in Crossref: 186] [Cited by in F6Publishing: 152] [Article Influence: 37.2] [Reference Citation Analysis]
Number Citing Articles
1 Tustumi F, Takeda FR, Viyuela MS, da Cruz Junior JB, Brandão AAGS, Sallum RAA, Ribeiro Junior U, Cecconello I. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer. J Surg Oncol 2020;121:784-94. [PMID: 31762058 DOI: 10.1002/jso.25778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Jayaprakasam VS, Yeh R, Ku GY, Petkovska I, Fuqua JL 3rd, Gollub M, Paroder V. Role of Imaging in Esophageal Cancer Management in 2020: Update for Radiologists. AJR Am J Roentgenol 2020;215:1072-84. [PMID: 32901568 DOI: 10.2214/AJR.20.22791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Leers JM, Knepper L, van der Veen A, Schröder W, Fuchs H, Schiller P, Hellmich M, Zettelmeyer U, Brosens LAA, Quaas A, Ruurda JP, van Hillegersberg R, Bruns CJ. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II. BMC Cancer 2020;20:781. [PMID: 32819399 DOI: 10.1186/s12885-020-07152-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wu L, Yang X, Cao W, Zhao K, Li W, Ye W, Chen X, Zhou Z, Liu Z, Liang C. Multiple Level CT Radiomics Features Preoperatively Predict Lymph Node Metastasis in Esophageal Cancer: A Multicentre Retrospective Study. Front Oncol. 2019;9:1548. [PMID: 32039021 DOI: 10.3389/fonc.2019.01548] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
5 Palanivelu C, Dey S, Sabnis S, Gupta R, Cumar B, Kumar S, Natarajan R, Ramakrishnan P. Robotic-assisted minimally invasive oesophagectomy for cancer: An initial experience. J Minim Access Surg 2019;15:234-41. [PMID: 29737322 DOI: 10.4103/jmas.JMAS_7_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Huang Z, Jin Y, Cai X, Chen L, Shen X, Li B, Chen H, Li Y. Association of the programmed death ligand‐1 combined positive score in tumors and clinicopathological features in esophageal cancer. Thoracic Cancer. [DOI: 10.1111/1759-7714.14285] [Reference Citation Analysis]
7 Masuike Y, Tanaka K, Makino T, Yamasaki M, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Mori M, Doki Y. Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosis. PLoS One 2018;13:e0193159. [PMID: 29447301 DOI: 10.1371/journal.pone.0193159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
8 Kamarajah SK, Marson EJ, Zhou D, Wyn-Griffiths F, Lin A, Evans RPT, Bundred JR, Singh P, Griffiths EA. Meta-analysis of prognostic factors of overall survival in patients undergoing oesophagectomy for oesophageal cancer. Dis Esophagus 2020;33:doaa038. [PMID: 32448903 DOI: 10.1093/dote/doaa038] [Reference Citation Analysis]
9 Didamson OC, Abrahamse H. Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine. Pharmaceutics 2021;13:1943. [PMID: 34834358 DOI: 10.3390/pharmaceutics13111943] [Reference Citation Analysis]
10 Nagaki Y, Motoyama S, Sato Y, Wakita A, Fujita H, Sasaki Y, Imai K, Minamiya Y. SUVmax reduction predicts long-term survival in patients of non-pCR both in the tumor and lymph nodes after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. World J Surg Oncol 2021;19:105. [PMID: 33836789 DOI: 10.1186/s12957-021-02208-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kang J, Lee HP, Kim HR, Kim JH, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Ahn JY, Ryu JS, Cho KJ, Lee MY, Kim SB, Kim YH, Park SR. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma. Surg Oncol 2020;35:491-7. [PMID: 33130441 DOI: 10.1016/j.suronc.2020.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Chung SK, Bludevich B, Cherng N, Zhang T, Crawford A, Maxfield MW, Whalen G, Uy K, Perugini RA. Paraconduit Hiatal Hernia Following Esophagectomy: Incidence, Risk Factors, Outcomes and Repair. J Surg Res 2021;268:276-83. [PMID: 34392181 DOI: 10.1016/j.jss.2021.06.059] [Reference Citation Analysis]
13 Yang Y, Su Y, Zhang X, Liu J, Zhang H, Li B, Hua R, Tan L, Chen H, Li Z. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial). Trials 2020;21:603. [PMID: 32611448 DOI: 10.1186/s13063-020-04461-5] [Reference Citation Analysis]
14 Li SM, Gong YX, Zhang ZZ, Zhang W, Liu ZQ, Li BZ. Effect of Radical Surgery for Advanced Adenocarcinoma of Esophagogastric Junction on Perioperative Cellular Cell Immunity. J Invest Surg 2021;34:134-41. [PMID: 31533488 DOI: 10.1080/08941939.2019.1606963] [Reference Citation Analysis]
15 Hsu P, Chien L, Lin C, Yeh Y, Chuang C, Hsu H, Wu Y, Hsu C. Impact of perineural invasion as a histopathological prognostic factor in ypStage II/III oesophageal squamous cell carcinoma†. European Journal of Cardio-Thoracic Surgery 2019;55:927-33. [DOI: 10.1093/ejcts/ezy380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hagens ERC, van Berge Henegouwen MI, Gisbertz SS. Distribution of Lymph Node Metastases in Esophageal Carcinoma Patients Undergoing Upfront Surgery: A Systematic Review. Cancers (Basel) 2020;12:E1592. [PMID: 32560226 DOI: 10.3390/cancers12061592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Tustumi F, Duarte PS, Albenda DG, Takeda FR, Sallum RAA, Junior UR, Buchpiguel CA, Cecconello I. Prognostic value of 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters measured in the primary tumor and suspicious lymph nodes before neoadjuvant therapy in patients with esophageal carcinoma. Nucl Med Commun 2021;42:437-43. [PMID: 33306638 DOI: 10.1097/MNM.0000000000001347] [Reference Citation Analysis]
18 Park JS, Van der Wall H, Kennedy C, Falk GL. Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated? World J Gastrointest Surg 2021; 13(10): 1235-1244 [PMID: 34754391 DOI: 10.4240/wjgs.v13.i10.1235] [Reference Citation Analysis]
19 Yamamoto S, Kato K, Daiko H, Kojima T, Hara H, Abe T, Tsubosa Y, Nagashima K, Aoki K, Mizoguchi Y, Kitano S, Yachida S, Shiba S, Kitagawa Y. Feasibility study of nivolumab as neoadjuvant chemotherapy for locally esophageal carcinoma: FRONTiER (JCOG1804E). Future Oncol 2020;16:1351-7. [PMID: 32396014 DOI: 10.2217/fon-2020-0189] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 Sharma P, Shaheen NJ, Katzka D, Bergman JJGHM. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.Gastroenterology. 2020;158:760-769. [PMID: 31730766 DOI: 10.1053/j.gastro.2019.09.051] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
21 Aboul-Enein MS, Knight W, Wulaningsih W, Foley DM, Dellaportas D, Zylstra J, Baker CR, Kelly M, Smyth E, Lagergren J, Maisey N, Allum WH, Gossage JA, Cunningham D, Davies AR; Guy's and St Thomas' Oesophago-gastric Research Group. The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma. J Surg Oncol 2021. [PMID: 34403501 DOI: 10.1002/jso.26648] [Reference Citation Analysis]
22 Wolfson P, Ho KMA, Bassett P, Haidry R, Olivo A, Lovat L, Sami SS. Accuracy of clinical staging for T2N0 oesophageal cancer: systematic review and meta-analysis. Dis Esophagus 2021;34:doab002. [PMID: 33618359 DOI: 10.1093/dote/doab002] [Reference Citation Analysis]
23 Zhang X, Jain D. Updates in staging and pathologic evaluation of esophageal carcinoma following neoadjuvant therapy. Ann N Y Acad Sci 2020;1482:163-76. [PMID: 32892349 DOI: 10.1111/nyas.14462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Wu H, Shang L, Du F, Fu M, Liu J, Fang Z, Li L. Transhiatal versus transthoracic surgical approach for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction: a meta-analysis. Expert Rev Gastroenterol Hepatol 2020;14:1107-17. [PMID: 32757864 DOI: 10.1080/17474124.2020.1806710] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 O'Rourke C, Welaratne I, Cournane S, McLoughlin LC, Reynolds JV, Johnston C, Sheehy N. Diagnostic accuracy of SUVmax in predicting malignancy of supraclavicular lymph nodes from primary oesophageal cancer. Eur J Radiol 2020;125:108860. [PMID: 32065926 DOI: 10.1016/j.ejrad.2020.108860] [Reference Citation Analysis]
26 Hu X, Wu L, Liu B, Chen K. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction. Front Immunol 2021;12:651056. [PMID: 34122409 DOI: 10.3389/fimmu.2021.651056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Sihag S, Nussenzweig SC, Walch HS, Hsu M, Tan KS, Sanchez-Vega F, Chatila WK, De La Torre SA, Patel A, Janjigian YY, Maron S, Ku GY, Tang LH, Hechtman J, Shah PM, Wu AJ, Jones DR, Molena D, Solit DB, Schultz N, Berger MF. Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways. Clin Cancer Res 2021;27:3491-8. [PMID: 33795256 DOI: 10.1158/1078-0432.CCR-20-4707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 van den Ende T, Ter Veer E, Machiels M, Mali RMA, Abe Nijenhuis FA, de Waal L, Laarman M, Gisbertz SS, Hulshof MCCM, van Oijen MGH, van Laarhoven HWM. The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis. Cancers (Basel) 2019;11:E80. [PMID: 30641964 DOI: 10.3390/cancers11010080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
29 Li F, Shang Y, Shi F, Zhang L, Yan J, Sun Q, She J. Expression of Integrin β6 and HAX-1 Correlates with Aggressive Features and Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:9599-608. [PMID: 33061645 DOI: 10.2147/CMAR.S274892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Gao Z, Hua B, Ge X, Liu J, Xue L, Zhen F, Luo J. Comparison Between Size and Stage of Preoperative Tumor Defined by Preoperative Magnetic Resonance Imaging and Postoperative Specimens After Radical Resection of Esophageal Cancer. Technol Cancer Res Treat 2019;18:1533033819876263. [PMID: 31551000 DOI: 10.1177/1533033819876263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tang M, Ge Y, Zhang Q, Zhang X, Xiao C, Li Q, Zhang X, Zhang K, Song M, Wang X, Yang M, Ruan G, Mu Y, Huang H, Cong M, Zhou F, Shi H. Near-term prognostic impact of integrated muscle mass and function in upper gastrointestinal cancer. Clin Nutr 2021;40:5169-79. [PMID: 34461591 DOI: 10.1016/j.clnu.2021.07.028] [Reference Citation Analysis]
32 Li DK, Haffar S, Horibe M, Homsi HA, Zukerberg L, Murad MH, Visrodia KH, Gala M, Katzka DA, Bazerbachi F. Verrucous esophageal carcinoma is a unique indolent subtype of squamous cell carcinoma: a systematic review and individual patient regression analysis. J Gastroenterol 2021;56:12-24. [PMID: 33079233 DOI: 10.1007/s00535-020-01736-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Ishida N, Miyazu T, Tamura S, Suzuki S, Tani S, Yamade M, Iwaizumi M, Osawa S, Hamaya Y, Shinmura K, Sugimura H, Miura K, Furuta T, Sugimoto K. Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report. World J Gastroenterol 2020; 26(45): 7263-7271 [PMID: 33362382 DOI: 10.3748/wjg.v26.i45.7263] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Mazer LM, Poultsides GA. What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer? Surg Clin North Am 2019;99:457-69. [PMID: 31047035 DOI: 10.1016/j.suc.2019.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
35 Be KH, Khor R, Lim Joon D, Starvaggi B, Chao M, Ng SP, Ng M, Zorron Cheng Tao Pu L, Efthymiou M, Vaughan R, Chandran S. Long-term clinical outcomes of lipiodol marking using standard gastroscopy for image-guided radiotherapy of upper gastrointestinal cancers. World J Gastroenterol 2021; 27(42): 7387-7401 [PMID: 34876797 DOI: 10.3748/wjg.v27.i42.7387] [Reference Citation Analysis]
36 Azzam O, Hewavitharana CH, Fermoyle S, Prentice D. Paraneoplastic leukemoid reaction in a localised squamous cell oesophageal cancer with paracrine G-CSF production. BMJ Case Rep 2020;13:e235069. [PMID: 33040032 DOI: 10.1136/bcr-2020-235069] [Reference Citation Analysis]
37 Hoang AT, Vizio B, Chiusa L, Cimino A, Solerio D, Do NH, Pileci S, Camandona M, Bellone G. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression. Int J Med Sci 2021;18:1406-14. [PMID: 33628097 DOI: 10.7150/ijms.52688] [Reference Citation Analysis]
38 Okadome K, Baba Y, Yasuda-Yoshihara N, Nomoto D, Yagi T, Toihata T, Ogawa K, Sawayama H, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Komohara Y, Baba H. PD-L1 and PD-L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma. Cancer Sci 2021. [PMID: 34773342 DOI: 10.1111/cas.15198] [Reference Citation Analysis]
39 Kuwabara H, Chiba H, Tachikawa J, Okada N, Ashikari K, Arimoto J, Nakaoka M, Sakai E, Goto T, Ohata K. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus. Dig Endosc 2020;32:621-7. [PMID: 31965622 DOI: 10.1111/den.13631] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Lemini R, Díaz Vico T, Trumbull DA, Attwood K, Spaulding AC, Elli EF, Colibaseanu DT, Kukar M, Gabriel E. Prognostic models for stage I-III esophageal cancer: a comparison between existing calculators. J Gastrointest Oncol 2021;12:1963-72. [PMID: 34790364 DOI: 10.21037/jgo-20-337] [Reference Citation Analysis]
41 Yeh JH, Huang RY, Lee CT, Lin CW, Hsu MH, Wu TC, Hsiao PJ, Wang WL. Long-term outcomes of endoscopic submucosal dissection and comparison to surgery for superficial esophageal squamous cancer: a systematic review and meta-analysis. Therap Adv Gastroenterol 2020;13:1756284820964316. [PMID: 33224272 DOI: 10.1177/1756284820964316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Hirose W, Taniyama Y, Fujishima F, Sato C, Unno M, Kamei T. Salvage esophagectomy for local recurrent esophageal cancer after definitive chemoradiotherapy followed by photodynamic therapy: A case report. Int J Surg Case Rep 2021;80:105617. [PMID: 33592421 DOI: 10.1016/j.ijscr.2021.02.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Yang PW, Lin MC, Huang PM, Wang CP, Chen TC, Chen CN, Tsai MH, Cheng JC, Chuang EY, Hsieh MS, Lou PJ, Lee JM. Risk Factors and Genetic Biomarkers of Multiple Primary Cancers in Esophageal Cancer Patients. Front Oncol 2020;10:585621. [PMID: 33552962 DOI: 10.3389/fonc.2020.585621] [Reference Citation Analysis]
44 Khalafi S, Lockhart AC, Livingstone AS, El-Rifai W. Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet? Cancers (Basel) 2020;12:E3077. [PMID: 33105560 DOI: 10.3390/cancers12113077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Park CH, Yang DH, Kim JW, Kim JH, Kim JH, Min YW, Lee SH, Bae JH, Chung H, Choi KD, Park JC, Lee H, Kwak MS, Kim B, Lee HJ, Lee HS, Choi M, Park DA, Lee JY, Byeon JS, Park CG, Cho JY, Lee ST, Chun HJ. Clinical practice guideline for endoscopic resection of early gastrointestinal cancer. Intest Res 2021;19:127-57. [PMID: 33045799 DOI: 10.5217/ir.2020.00020] [Reference Citation Analysis]
46 Martínez A, Infante JR, Quirós J, Rayo JI, Serrano J, Moreno M, Jiménez P, Cobo A, Baena A. Baseline 18F-FDG PET/CT quantitative parameters as prognostic factors in esophageal squamous cell cancer. Rev Esp Med Nucl Imagen Mol 2021:S2253-654X(21)00107-4. [PMID: 34088649 DOI: 10.1016/j.remn.2021.03.016] [Reference Citation Analysis]
47 Othman MO, Lee JH, Wang K. Clinical Practice Update on the Utility of Endoscopic Submucosal Dissection in T1b Esophageal Cancer: Expert Review. Clin Gastroenterol Hepatol 2019;17:2161-6. [PMID: 31401148 DOI: 10.1016/j.cgh.2019.05.045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
48 Shin A, Won YJ, Jung HK, Kong HJ, Jung KW, Oh CM, Choe S, Lee J. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database. J Gastroenterol Hepatol 2018;33:1961-8. [PMID: 29802647 DOI: 10.1111/jgh.14289] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
49 McCarty JC, Parker RK, Vidri RJ, Robinson KA, Lipsitz S, Gangadharan SP, Iyer PG. A retrospective cohort study of endoscopic therapy and esophagectomy for stage 1 esophageal cancer: less is more. Gastrointest Endosc 2020;92:23-30. [PMID: 32276764 DOI: 10.1016/j.gie.2020.01.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
50 Koemans WJ, van Dieren JM, van den Berg JG, Meijer GA, Snaebjornsson P, Chalabi M, Lecot F, Riedl R, Krijgsman O, Hofland I, Broeks A, Voncken FEM, Peppelenbosch MP, Sosef MN, van Sandick JW, Kodach LL. High CD8+ tumour-infiltrating lymphocyte density associates with unfavourable prognosis in oesophageal adenocarcinoma following poor response to neoadjuvant chemoradiotherapy. Histopathology 2021;79:238-51. [PMID: 33660299 DOI: 10.1111/his.14361] [Reference Citation Analysis]
51 Bonde A, Daly S, Kirsten J, Kondapaneni S, Mellnick V, Menias CO, Katabathina VS. Human Gut Microbiota-associated Gastrointestinal Malignancies: A Comprehensive Review. Radiographics 2021;41:1103-22. [PMID: 33989072 DOI: 10.1148/rg.2021200168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Oesophago-Gastric Anastomosis Study Group (OGAA) on behalf of the West Midlands Research Collaborative . Postoperative outcomes in oesophagectomy with trainee involvement. BJS Open 2021;5:zrab132. [PMID: 35038327 DOI: 10.1093/bjsopen/zrab132] [Reference Citation Analysis]
53 Mitchell DP, Yeluri S, Van der Wall H, Falk GL. The real risk of nodal disease in T1 oesophageal adenocarcinoma: A systematic review. Eur Surg 2020;52:110-7. [DOI: 10.1007/s10353-019-00627-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, Falay O, Karahasanoğlu T, Selçukbiricik F, Selek U, Atalar B, Balık E, Tözün N, Rozanes İ, Arıcan A, Hamzaoğlu İ, Baca B, Molinas Mandel N, Saruç M, Göksel S, Demir G, Ağaoğlu F, Yakıcıer C, Özbek U, Özben V, Özyar E, Güner AL, Er Ö, Kaban K, Bölükbaşı Y, Buğra D, Group Tİ. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group. Turk J Gastroenterol 2019;30:584-98. [PMID: 30541724 DOI: 10.5152/tjg.2018.18737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Wu N, Zhu Y, Xu X, Zhu Y, Song Y, Pang L, Chen Z. The anti-tumor effects of dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A on inducing autophagy in esophageal squamous cell carcinoma. J Cancer 2018;9:987-97. [PMID: 29581778 DOI: 10.7150/jca.22861] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
56 Lin SH, Lee JM, Wu IH. Comparison of Clinical Outcomes between Salvage and Elective Thoracic Endovascular Aortic Repair in Patients with Advanced Esophageal Cancer with Aortic Invasion: A Retrospective Cohort Study. Biomedicines 2021;9:1889. [PMID: 34944705 DOI: 10.3390/biomedicines9121889] [Reference Citation Analysis]
57 Deo KB, Singh H, Gupta V, Das A, Verma GR, Gupta R. Thoracoscopy-Assisted Esophagectomy vs Transhiatal Esophagectomy for Carcinoma Esophagus: a Prospective Comparison of Short-Term Outcomes. J Gastrointest Cancer 2021. [PMID: 33629171 DOI: 10.1007/s12029-021-00607-z] [Reference Citation Analysis]
58 Shah MA, Kennedy EB, Catenacci DV, Deighton DC, Goodman KA, Malhotra NK, Willett C, Stiles B, Sharma P, Tang L, Wijnhoven BPL, Hofstetter WL. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. J Clin Oncol 2020;38:2677-94. [PMID: 32568633 DOI: 10.1200/JCO.20.00866] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 9.5] [Reference Citation Analysis]
59 Zhang W, Chen H, Zhang G, Jin G. A nomogram for predicting lymph node metastasis in superficial esophageal squamous cell carcinoma. J Biomed Res 2021;35:361-70. [PMID: 34628403 DOI: 10.7555/JBR.35.20210034] [Reference Citation Analysis]
60 Zhou N, Rajaram R, Hofstetter WL. Management of Locally Advanced Esophageal Cancer. Surg Oncol Clin N Am 2020;29:631-46. [PMID: 32883463 DOI: 10.1016/j.soc.2020.06.003] [Reference Citation Analysis]
61 Lin J, He J, Chen S, Lin J, Han Z, Chen M, Yu S, Gao L, Peng K, Shen Z, Zhang P, Kang M. Outcomes of minimally invasive total mesoesophageal excision: a propensity score-matched analysis. Surg Endosc 2021. [PMID: 34845550 DOI: 10.1007/s00464-021-08634-4] [Reference Citation Analysis]
62 Wei MT, Friedland S. Early Esophageal Cancer: What the Gastroenterologist Needs to Know. Gastroenterol Clin North Am 2021;50:791-808. [PMID: 34717871 DOI: 10.1016/j.gtc.2021.07.004] [Reference Citation Analysis]
63 Matsuda S, Kawakubo H, Takeuchi H, Hayashi M, Mayanagi S, Takemura R, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma. Br J Surg 2020;107:705-11. [PMID: 32077101 DOI: 10.1002/bjs.11487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
64 Izadi F, Sharpe BP, Breininger SP, Secrier M, Gibson J, Walker RC, Rahman S, Devonshire G, Lloyd MA, Walters ZS, Fitzgerald RC, Rose-Zerilli MJJ, Underwood TJ, On Behalf Of Occams. Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma. Cancers (Basel) 2021;13:3394. [PMID: 34298611 DOI: 10.3390/cancers13143394] [Reference Citation Analysis]
65 Koch OO, Weitzendorfer M, Varga M, Tschoner A, Partl R, Perathoner A, Gehwolf P, Kapp KS, Függer R, Öfner D, Emmanuel K. Perioperative chemotherapy versus neoadjuvant chemoradiation for patients with adenocarcinoma of the distal esophagus in Austria: a retrospective analysis. World J Surg Oncol 2019;17:146. [PMID: 31426805 DOI: 10.1186/s12957-019-1693-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
66 De Pasqual CA, van der Sluis PC, Weindelmayer J, Lagarde SM, Giacopuzzi S, De Manzoni G, Wijnhoven BPL. Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: a multicenter retrospective cohort study. Dis Esophagus 2021:doab090. [PMID: 34969080 DOI: 10.1093/dote/doab090] [Reference Citation Analysis]
67 Kalff MC, Vesseur I, Eshuis WJ, Heineman DJ, Daams F, van der Peet DL, van Berge Henegouwen MI, Gisbertz SS. The Association of Textbook Outcome and Long-Term Survival After Esophagectomy for Esophageal Cancer. Ann Thorac Surg 2021;112:1134-41. [PMID: 33221197 DOI: 10.1016/j.athoracsur.2020.09.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Kamarajah SK, Newton N, Navidi M, Wahed S, Immanuel A, Hayes N, Griffin SM, Phillips AW. Long-term outcomes of clinical and pathological-staged T3 N3 esophageal cancer. Dis Esophagus 2020;33:doz109. [PMID: 31950184 DOI: 10.1093/dote/doz109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Martínez A, Infante JR, Quirós J, Rayo JI, Serrano J, Moreno M, Jiménez P, Cobo A, Baena A. Baseline 18F-FDG PET/CT quantitative parameters as prognostic factors in esophageal squamous cell cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021:S2253-8089(21)00127-0. [PMID: 34452867 DOI: 10.1016/j.remnie.2021.07.006] [Reference Citation Analysis]
70 D'Ugo D, Agnes A, Grieco M, Biondi A, Persiani R. Global updates in the treatment of gastric cancer: a systematic review. Part 2: perioperative management, multimodal therapies, new technologies, standardization of the surgical treatment and educational aspects. Updates Surg 2020;72:355-78. [PMID: 32306277 DOI: 10.1007/s13304-020-00771-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Hirata A, Hayano K, Ohira G, Imanishi S, Hanaoka T, Toyozumi T, Murakami K, Aoyagi T, Shuto K, Matsubara H. Volumetric Histogram Analysis of Apparent Diffusion Coefficient as a Biomarker to Predict Survival of Esophageal Cancer Patients. Ann Surg Oncol 2020;27:3083-9. [PMID: 32100222 DOI: 10.1245/s10434-020-08270-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Fatehi Hassanabad A, Chehade R, Breadner D, Raphael J. Esophageal carcinoma: Towards targeted therapies. Cell Oncol (Dordr) 2020;43:195-209. [PMID: 31848929 DOI: 10.1007/s13402-019-00488-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
73 Anconina R, Ortega C, Metser U, Liu ZA, Suzuki C, McInnis M, Darling GE, Wong R, Taylor K, Yeung J, Chen EX, Swallow CJ, Bajwa J, Jang RW, Elimova E, Veit-Haibach P. Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer. Eur J Nucl Med Mol Imaging 2021. [PMID: 34491404 DOI: 10.1007/s00259-021-05514-w] [Reference Citation Analysis]
74 Ye P, Yang Y, Zhang L, Zheng G. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data. Front Oncol 2021;11:658262. [PMID: 34676158 DOI: 10.3389/fonc.2021.658262] [Reference Citation Analysis]
75 Pischik VG. Editorial comments for neoadjuvant chemo-radiotherapy in the treatment of locally advanced squamous cell esophageal cancer. J Thorac Dis 2018;10:5979-81. [PMID: 30622767 DOI: 10.21037/jtd.2018.10.81] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
76 Yao C, Yu H, Zhou G, Xu J, Gu D, Yin L, He X, Xia H. Tumor-infiltrating plasma cells are the promising prognosis marker for esophageal squamous cell carcinoma. Esophagus 2021;18:574-84. [PMID: 33689055 DOI: 10.1007/s10388-021-00828-y] [Reference Citation Analysis]
77 Yanni F, Singh P, Tewari N, Parsons SL, Catton JA, Duffy J, Welch NT, Vohra RS. Comparison of Outcomes with Semi-mechanical and Circular Stapled Intrathoracic Esophagogastric Anastomosis following Esophagectomy. World J Surg 2019;43:2483-9. [PMID: 31222637 DOI: 10.1007/s00268-019-05057-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
78 Zanoni A. Nodal downstaging in esophageal and esophagogastric junction cancer: more important than ever. J Thorac Dis 2017;9:1839-42. [PMID: 28839979 DOI: 10.21037/jtd.2017.06.126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
79 Chang X, Guo X, Li X, Han X, Li X, Liu X, Ren J. Potential Value of Radiomics in the Identification of Stage T3 and T4a Esophagogastric Junction Adenocarcinoma Based on Contrast-Enhanced CT Images. Front Oncol 2021;11:627947. [PMID: 33747947 DOI: 10.3389/fonc.2021.627947] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Gupta V, Levy J, Allen-Ayodabo C, Amirazodi E, Davis L, Li Q, Mahar A, Coburn NG; PRESTO Study Investigators. Population Registry of Esophageal and Stomach Tumours in Ontario (PRESTO): protocol for a multicentre clinical and pathological database including 25 000 patients. BMJ Open 2020;10:e032729. [PMID: 32474423 DOI: 10.1136/bmjopen-2019-032729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Rahman SA, Maynard N, Trudgill N, Crosby T, Park M, Wahedally H, Underwood TJ, Cromwell DA; NOGCA Project Team and AUGIS. Prediction of long-term survival after gastrectomy using random survival forests. Br J Surg 2021:znab237. [PMID: 34297818 DOI: 10.1093/bjs/znab237] [Reference Citation Analysis]
82 Yang J, Lu Z, Li L, Li Y, Tan Y, Zhang D, Wang A. Relationship of lymphovascular invasion with lymph node metastasis and prognosis in superficial esophageal carcinoma: systematic review and meta-analysis. BMC Cancer 2020;20:176. [PMID: 32131772 DOI: 10.1186/s12885-020-6656-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
83 Chen YH, Lu HI, Wang YM, Lo CM, Chou SY, Huang CH, Shih LH, Chen SW, Li SH. The prognostic significance of celiac lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy. Oncotarget 2017;8:96190-202. [PMID: 29221198 DOI: 10.18632/oncotarget.21878] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
84 Tustumi F, Takeda FR, Brandão AAGS, Sallum RAA, Ribeiro Junior U, Cecconello I. LYMPHOCYTE COUNT AND PLATELET VOLUME PREDICTS POSTOPERATIVE COMPLICATIONS IN ESOPHAGECTOMY FOR CANCER: A COHORT STUDY. Arq Gastroenterol 2019;56:377-85. [PMID: 31618397 DOI: 10.1590/S0004-2803.201900000-70] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
85 Vendrely V, Launay V, Najah H, Smith D, Collet D, Gronnier C. Prognostic factors in esophageal cancer treated with curative intent. Dig Liver Dis 2018;50:991-6. [PMID: 30166221 DOI: 10.1016/j.dld.2018.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
86 Auld M, Srinath H, Jeyarajan E. Oesophageal Squamous Dysplasia. J Gastrointest Cancer. 2018;49:385-388. [PMID: 29806061 DOI: 10.1007/s12029-018-0122-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
87 Sharkey AR, Sah BR, Withey SJ, Bhuva S, Neji R, Jeljeli S, Green A, Cook GJR, Goh V; Guy’s & St Thomas’ Oesophago-Gastric Research Group. Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI. Eur J Hybrid Imaging 2021;5:23. [PMID: 34897589 DOI: 10.1186/s41824-021-00117-y] [Reference Citation Analysis]
88 Tu CC, Hsu PK. Current choices and prospects in management of postoperative esophageal cancer patients. Asian J Surg 2019;42:81-4. [PMID: 30121147 DOI: 10.1016/j.asjsur.2018.06.009] [Reference Citation Analysis]
89 Khaitan PG, Watson TJ. The significance of pathological extracapsular vs. intracapsular lymph node involvement in patients with resectable esophageal cancer after neoadjuvant therapy. J Thorac Dis 2018;10:79-82. [PMID: 29600026 DOI: 10.21037/jtd.2017.12.15] [Reference Citation Analysis]
90 Strizova Z, Snajdauf M, Stakheev D, Taborska P, Vachtenheim J Jr, Biskup J, Lischke R, Bartunkova J, Smrz D. The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients. J Cancer Res Clin Oncol 2020;146:1979-92. [PMID: 32447483 DOI: 10.1007/s00432-020-03258-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
91 Schlosser T, Hoffmeister A, Feisthammel J, Niebisch S, Thieme R, Gockel I. [Treatment recommendations for early esophageal cancer : Endoscopic and surgical options]. Chirurg 2021;92:1077-84. [PMID: 34622303 DOI: 10.1007/s00104-021-01513-7] [Reference Citation Analysis]
92 Iwabu J, Namikawa T, Yokota K, Kitagawa H, Kihara K, Hirose N, Hanazaki K. Successful management of aortoesophageal fistula caused by esophageal cancer using thoracic endovascular aortic repair. Clin J Gastroenterol 2020;13:678-82. [PMID: 32449088 DOI: 10.1007/s12328-020-01132-5] [Reference Citation Analysis]
93 Lokanatha D, Hassan SA, Jacob LA, Suresh Babu MC, Lokesh KN, Rudresha AH, Rajeev LK, Saldanha S, Thottian AGF. Socioeconomic and administrative factors associated with treatment delay of esophageal and gastric carcinoma: Prospective study from a tertiary care centre in a developing country. Cancer Epidemiol 2020;67:101770. [PMID: 32593160 DOI: 10.1016/j.canep.2020.101770] [Reference Citation Analysis]
94 Gui Z, Liu H, Shi W, Xu Y, Qian H, Wang F. A Nomogram for Predicting the Risk of Radiotherapy-Related Esophageal Fistula in Esophageal Cancer Patients. Front Oncol 2022;11:785850. [DOI: 10.3389/fonc.2021.785850] [Reference Citation Analysis]
95 Jomrich G, Kollmann D, Wilfing L, Radosavljevic S, Ramazanova D, Ristl R, Grose RP, Ilhan-Mutlu A, Preusser M, Fassnacht C, Tsai YC, Guenova E, Schoppmann SF. Programmed death ligand 2 expression plays a limited role in adenocarcinomas of the gastroesophageal junction after preoperative chemotherapy. Eur Surg 2021;53:287-93. [PMID: 34868284 DOI: 10.1007/s10353-021-00700-4] [Reference Citation Analysis]
96 Kammili A, Kaneva P, Lee L, Cools-Lartigue J, Ferri LE, Mueller CL. Perioperative Transfusions for Gastroesophageal Cancers: Risk Factors and Short- and Long-Term Outcomes. J Gastrointest Surg 2021;25:48-57. [PMID: 33159242 DOI: 10.1007/s11605-020-04845-7] [Reference Citation Analysis]
97 Chen C, Ma Z, Shang X, Duan X, Yue J, Jiang H. Risk factors for lymph node metastasis of the left recurrent laryngeal nerve in patients with esophageal squamous cell carcinoma. Ann Transl Med 2021;9:476. [PMID: 33850873 DOI: 10.21037/atm-21-377] [Reference Citation Analysis]
98 Guo W, Zhang F, Shao F, Wang P, Li Z, Yang X, He Z, Shi S, Gao Y, He J. PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma. Hum Pathol 2019;84:291-8. [PMID: 30296523 DOI: 10.1016/j.humpath.2018.09.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
99 Oya S, Yamashita H, Iwata R, Kawasaki K, Tanabe A, Yagi K, Aikou S, Seto Y. Perioperative fluid dynamics evaluated by bioelectrical impedance analysis predict infectious surgical complications after esophagectomy. BMC Surg 2019;19:184. [PMID: 31791292 DOI: 10.1186/s12893-019-0652-z] [Reference Citation Analysis]
100 Lütken CD, Fiehn AK, Federspiel B, Achiam MP. Impact of isolated tumor cells in regional lymph nodes in adeno-and squamous cell carcinoma of the esophagus and the esophagogastric junction-A systematic review. Pathol Res Pract 2019;215:849-54. [PMID: 30723054 DOI: 10.1016/j.prp.2019.01.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
101 Ekeke CN, Chan EG, Fabian T, Villa-Sanchez M, Luketich JD. Recommendations for Surveillance and Management of Recurrent Esophageal Cancer Following Endoscopic Therapies. Surg Clin North Am 2021;101:415-26. [PMID: 34048762 DOI: 10.1016/j.suc.2021.03.004] [Reference Citation Analysis]
102 Yang Z, Yang F, Yang M, Qi Y, Jiang M, Xuan J, Liu Y, Tao H, Liu Y, Wang F. Prediction of overall survival in patients with Stage I esophageal cancer: A novel web-based calculator. J Surg Oncol 2021. [PMID: 34263466 DOI: 10.1002/jso.26594] [Reference Citation Analysis]
103 Thota PN, Alkhayyat M, Gomez Cifuentes JD, Haider M, Bena J, McMichael J, Sohal DP, Raja S, Sanaka MR. Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma. J Clin Gastroenterol 2021;Publish Ahead of Print. [PMID: 33405434 DOI: 10.1097/MCG.0000000000001489] [Reference Citation Analysis]
104 Li J, Mei X, Sun D, Guo M, Xie M, Chen X. A Nutrition and Inflammation-Related Nomogram to Predict Overall Survival in Surgically Resected Esophageal Squamous Cell Carcinoma (ESCC) Patients. Nutr Cancer 2021;:1-11. [PMID: 34369223 DOI: 10.1080/01635581.2021.1957131] [Reference Citation Analysis]
105 Xu H, Wu S, Luo H, Chen C, Lin L, Huang H, Xue R. Prognostic value of tumor length and diameter for esophageal squamous cell cancer patients treated with definitive (chemo)radiotherapy: Potential indicators for nonsurgical T staging. Cancer Med 2019;8:6326-34. [PMID: 31486278 DOI: 10.1002/cam4.2532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
106 Yang Y, Zheng J, Li Y. Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes. Eur J Surg Oncol 2021:S0748-7983(21)00942-2. [PMID: 34876328 DOI: 10.1016/j.ejso.2021.11.133] [Reference Citation Analysis]
107 Charalampakis N, Tsakatikas S, Schizas D, Kykalos S, Tolia M, Fioretzaki R, Papageorgiou G, Katsaros I, Abdelhakeem AAF, Sewastjanow-Silva M, Rogers JE, Ajani JA. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives. World J Gastrointest Oncol 2022; 14(1): 181-202 [DOI: 10.4251/wjgo.v14.i1.181] [Reference Citation Analysis]
108 Saleh M, Javadi S, Elsherif S, Patnana M, Sagebiel TL, Torres-Cabala C, Matei J, Bhosale P, Faria SC. Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to Treatment. Radiographics 2021;41:1954-72. [PMID: 34678102 DOI: 10.1148/rg.2021210063] [Reference Citation Analysis]
109 Wang A, Tan Y, Zhang Y, Xu D, Fang Y, Chen X, Wang S. The prognostic role of angiolymphatic invasion in N0 esophageal carcinoma: a meta-analysis and systematic review. J Thorac Dis 2019;11:3276-83. [PMID: 31559030 DOI: 10.21037/jtd.2019.08.50] [Reference Citation Analysis]
110 Lindenmann J, Fediuk M, Fink-Neuboeck N, Porubsky C, Pichler M, Brcic L, Anegg U, Balic M, Dandachi N, Maier A, Smolle M, Smolle J, Smolle-Juettner FM. Hazard Curves for Tumor Recurrence and Tumor-Related Death Following Esophagectomy for Esophageal Cancer. Cancers (Basel) 2020;12:E2066. [PMID: 32726927 DOI: 10.3390/cancers12082066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Wang A, Tan Y, Geng X, Chen X, Wang S. Lymphovascular invasion as a poor prognostic indicator in thoracic esophageal carcinoma: a systematic review and meta-analysis. Diseases of the Esophagus 2018;32. [DOI: 10.1093/dote/doy083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
112 Chen Y, Yeh C, Wen Y, Chuang W, Chao Y. Do dysplastic proximal resection margins predict the risk of anastomotic recurrence and overall survival in patients with esophageal squamous cell carcinoma? Diseases of the Esophagus 2018;32:doy090. [DOI: 10.1093/dote/doy090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 Lin G, Liu H, Li J. Pattern of recurrence and prognostic factors in patients with pT1-3 N0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience. J Cardiothorac Surg 2019;14:58. [PMID: 30866983 DOI: 10.1186/s13019-019-0883-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
114 Dinneen K, Baird AM, Ryan C, Sheils O. The Role of Cancer Stem Cells in Drug Resistance in Gastroesophageal Junction Adenocarcinoma. Front Mol Biosci 2021;8:600373. [PMID: 33628765 DOI: 10.3389/fmolb.2021.600373] [Reference Citation Analysis]
115 Triantafyllou T, Wijnhoven BPL. Current status of esophageal cancer treatment. Chin J Cancer Res 2020;32:271-86. [PMID: 32694894 DOI: 10.21147/j.issn.1000-9604.2020.03.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
116 Matsuda S, Kawakubo H, Takeuchi H, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Prognostic impact of thoracic duct lymph node metastasis in esophageal squamous cell carcinoma. Ann Gastroenterol Surg 2021;5:321-30. [PMID: 34095722 DOI: 10.1002/ags3.12432] [Reference Citation Analysis]
117 Ozawa H, Kawakubo H, Takeuchi M, Ishibashi Y, Matsuda S, Mayanagi S, Takemura R, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Prognostic Significance of the Number and Extent of Metastatic Lymph Nodes in Patients with Esophageal Cancer: Comparison of the Union for International Cancer Control 8th Edition and Japan Esophageal Society Japanese Classification of Esophageal Cancer 11th Edition Classifications for Esophageal Cancer. Ann Surg Oncol 2021. [PMID: 33748898 DOI: 10.1245/s10434-020-09545-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Ma DW, Cho Y, Jeon MJ, Kim JH, Lee IJ, Youn YH, Park JJ, Jung DH, Park H, Lee CG, Kim JW, Jeung HC. Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer. Front Oncol 2019;9:366. [PMID: 31139564 DOI: 10.3389/fonc.2019.00366] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
119 Jeremiasen M, Borg D, Hedner C, Svensson M, Nodin B, Leandersson K, Johansson J, Jirström K. Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma. Front Oncol 2020;10:534761. [PMID: 33194593 DOI: 10.3389/fonc.2020.534761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
120 Sumazaki M, Kaneko K, Ito M, Oshima Y, Saito F, Ogata H, Shibuya K, Shimada H. A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients. Am J Case Rep 2020;21:e922004. [PMID: 32312948 DOI: 10.12659/AJCR.922004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Shipe ME, Baechle JJ, Deppen SA, Gillaspie EA, Grogan EL. Modeling the impact of delaying surgery for early esophageal cancer in the era of COVID-19. Surg Endosc 2021;35:6081-8. [PMID: 33140152 DOI: 10.1007/s00464-020-08101-6] [Reference Citation Analysis]
122 Philippron A, Depypere L, Oeyen S, De Laere B, Vandeputte C, Nafteux P, De Preter K, Pattyn P. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma. PLoS One 2021;16:e0251052. [PMID: 33961658 DOI: 10.1371/journal.pone.0251052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Bravo-Iñiguez CE, He Z, Dezube AR, Mazzola E, Yelamanchili N, Zhao L, Bueno R, Swanson SJ, White A, Wiener DC, Jaklitsch MT, Wee JO. Impact of radial margins after esophagectomy for esophageal cancer. Eur J Surg Oncol 2021;47:2313-22. [PMID: 33714649 DOI: 10.1016/j.ejso.2021.02.014] [Reference Citation Analysis]
124 Betancourt-Cuellar SL, Benveniste MFK, Palacio DP, Hofstetter WL. Esophageal Cancer: Tumor-Node-Metastasis Staging. Radiol Clin North Am 2021;59:219-29. [PMID: 33551083 DOI: 10.1016/j.rcl.2020.11.008] [Reference Citation Analysis]
125 Siddiki HA, Lam-himlin DM, Kahn A, Bandres MV, Burdick GE, Crowell MD, Pannala R, Ramirez FC, Vela MF, Fleischer DE. Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett’s esophagus. Gastrointestinal Endoscopy 2019;89:759-68. [DOI: 10.1016/j.gie.2018.10.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
126 Cameniţă D, Demetrian AD, Pleşea RM, Tănasie-Vasile MI, Strâmbu VDE, Grigorean VT, Ioniţă E, Pleşea IE, Marincaş AM. Clinical-morphological profiles of esophageal carcinoma's main types. Rom J Morphol Embryol 2020;61:407-22. [PMID: 33544792 DOI: 10.47162/RJME.61.2.10] [Reference Citation Analysis]
127 Chen YJ, Yeh ST, Kao PS, Ou LH, Lin CS. A reappraisal of lymph node dissection in colorectal cancer during primary surgical resection. World J Surg Oncol 2020;18:97. [PMID: 32418536 DOI: 10.1186/s12957-020-01863-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
128 Nagaki Y, Motoyama S, Sato Y, Wakita A, Fujita H, Sasaki Y, Imai K, Minamiya Y. Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy. BMC Cancer 2021;21:1192. [PMID: 34753448 DOI: 10.1186/s12885-021-08918-x] [Reference Citation Analysis]
129 Mamdani H, Birdas T, Jalal SI. Role of surgery following neoadjuvant chemoradiation in patients with lymph node positive locally advanced esophageal adenocarcinoma: a national cancer database analysis. J Gastrointest Oncol 2021;12:1944-50. [PMID: 34790362 DOI: 10.21037/jgo-21-314] [Reference Citation Analysis]
130 Mukherjee P, Lim TC, Chawla A. Imaging of the Esophagus. In: Chawla A, editor. Thoracic Imaging. Singapore: Springer; 2019. pp. 295-324. [DOI: 10.1007/978-981-13-2544-1_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
131 Gruber ES, Oberhuber G, Birner P, Schlederer M, Kenn M, Schreiner W, Jomrich G, Schoppmann SF, Gnant M, Tse W, Kenner L. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019;8:E1357. [PMID: 31671695 DOI: 10.3390/cells8111357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
132 Gombodorj N, Yokobori T, Tanaka N, Suzuki S, Kuriyama K, Kumakura Y, Yoshida T, Sakai M, Sohda M, Baatar S, Miyazaki T, Nishiyama M, Shirabe K, Kuwano H. Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study: GOMBODORJ et al.. J Surg Oncol 2018;118:101-8. [DOI: 10.1002/jso.25127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
133 Renelus BD, Jamorabo DS, Kancharla P, Paul S, Dave N, Briggs WM, Peterson SJ. Racial Disparities with Esophageal Cancer Mortality at a High-Volume University Affiliated Center: An All ACCESS Invitation. J Natl Med Assoc 2020;112:478-83. [PMID: 31072644 DOI: 10.1016/j.jnma.2019.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 den Bakker CM, van der Peet DL. Post-treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma. Ann Surg 2018;268:e78-9. [PMID: 29342015 DOI: 10.1097/SLA.0000000000002669] [Reference Citation Analysis]
135 Inada M, Nishimura Y, Ishikawa K, Nakamatsu K, Wada Y, Uehara T, Fukuda K, Anami S, Doi H, Kanamori S. Comparing the 7th and 8th editions of the American Joint Committee on Cancer/Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma treated by definitive radiotherapy. Esophagus. 2019;16:371-376. [PMID: 31111308 DOI: 10.1007/s10388-019-00675-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
136 Akin EA, Qazi ZN, Osman M, Zeman RK. Clinical impact of FDG PET/CT in alimentary tract malignancies: an updated review. Abdom Radiol (NY) 2020;45:1018-35. [PMID: 32152644 DOI: 10.1007/s00261-020-02447-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
137 Manning MA, Shafa S, Mehrotra AK, Grenier RE, Levy AD. Role of Multimodality Imaging in Gastroesophageal Reflux Disease and Its Complications, with Clinical and Pathologic Correlation. Radiographics 2020;40:44-71. [PMID: 31917657 DOI: 10.1148/rg.2020190029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Lorton CM, Higgins L, O'Donoghue N, Donohoe C, O'Connell J, Mockler D, Reynolds JV, Walsh D, Lysaght J. C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-Analysis. Ann Surg Oncol 2021. [PMID: 34773194 DOI: 10.1245/s10434-021-10988-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Tomita Y, Moldovan M, Chang Lee R, Hsieh AH, Townsend A, Price T. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma. Cochrane Database Syst Rev 2020;11:CD012078. [PMID: 33210731 DOI: 10.1002/14651858.CD012078.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Yeheyis ET, Kassa S, Yeshitela H, Bekele A. Intraoperative hypotension is not associated with adverse short-term postoperative outcomes after esophagectomy in esophageal cancer patients. BMC Surg 2021;21:1. [PMID: 33388031 DOI: 10.1186/s12893-020-01015-z] [Reference Citation Analysis]
141 Sanz Álvarez L, Turienzo Santos E, Rodicio Miravalles JL, Moreno Gijón M, Amoza Pais S, Sanz Navarro S, Rizzo Ramos A. Evidence in follow-up and prognosis of esophagogastric junction cancer. Cir Esp (Engl Ed) 2019;97:465-9. [PMID: 31060735 DOI: 10.1016/j.ciresp.2019.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Vermeulen BD, Bruggeman L, Bac DJ, Schrauwen RWM, Epping LSM, Scheffer RCH, Tan ACITL, Groenen MJM, Verhoeven RHA, Siersema PD. Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a population-based study. Acta Oncol. 2020;59:410-416. [PMID: 32067535 DOI: 10.1080/0284186x.2020.1725240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
143 Cooper L, Dezube AR, De León LE, Kucukak S, Mazzola E, Dumontier C, Mamon H, Enzinger P, Jaklitsch MT, Frain LN, Wee JO. Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer. Eur J Surg Oncol 2021:S0748-7983(21)00418-2. [PMID: 33895020 DOI: 10.1016/j.ejso.2021.04.013] [Reference Citation Analysis]
144 Wang X, Sweigert P, Eguia E, Varsnik MA, Renz CR, Terrasse WA, Gauthier M, Aranha G, Knab LM, Abood G. Impact of angiotensin system inhibitors on esophageal cancer survival. Surg Open Sci 2021;3:34-8. [PMID: 33554099 DOI: 10.1016/j.sopen.2020.08.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Hosogi H, Sakaguchi M, Yagi D, Onishi R, Hashimoto Y, Sakai Y, Kanaya S. Side-overlap esophagogastric tube (SO-EG) reconstruction after minimally invasive Ivor Lewis esophagectomy or laparoscopic proximal gastrectomy for cancer of the esophagogastric junction. Langenbecks Arch Surg 2021. [PMID: 34775522 DOI: 10.1007/s00423-021-02377-5] [Reference Citation Analysis]
146 Cabral F, Cruz A, Casaca R, Monteiro C, Ramos P, Pedro C, Brandão F, Fonseca R, Ratão P, Salgado L, Pinto I, Abecasis N. Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic response. Cancer Radiother 2020;24:834-41. [PMID: 33191120 DOI: 10.1016/j.canrad.2020.05.013] [Reference Citation Analysis]
147 Sato H, Terai S, Shimamura Y, Tanaka S, Shiwaku H, Minami H, Sato C, Ogawa R, Yokomichi H, Inoue H. Achalasia and esophageal cancer: a large database analysis in Japan. J Gastroenterol 2021;56:360-70. [PMID: 33538893 DOI: 10.1007/s00535-021-01763-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Wondimagegnehu A, Hirpa S, Abaya SW, Gizaw M, Getachew S, Ayele W, Yirgu R, Demeke T, Dessalegn B, Diribi J, Kaba M, Assefa M, Jemal A, Kantelhardt EJ, Addissie A. Oesophageal cancer magnitude and presentation in Ethiopia 2012-2017. PLoS One 2020;15:e0242807. [PMID: 33259514 DOI: 10.1371/journal.pone.0242807] [Reference Citation Analysis]
149 Takeda FR, Tustumi F, de Almeida Obregon C, Yogolare GG, Navarro YP, Segatelli V, Sallum RAA, Junior UR, Cecconello I. Prognostic Value of Tumor Regression Grade Based on Ryan Score in Squamous Cell Carcinoma and Adenocarcinoma of Esophagus. Ann Surg Oncol 2020;27:1241-7. [DOI: 10.1245/s10434-019-07967-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
150 Wu H, Yu Y, Zheng Q, Liu T, Wu Y, Wang Z, Zheng H, Liu L, Li J. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma. Radiat Oncol 2021;16:207. [PMID: 34717670 DOI: 10.1186/s13014-021-01931-1] [Reference Citation Analysis]
151 Hirata A, Hayano K, Ohira G, Imanishi S, Hanaoka T, Murakami K, Aoyagi T, Shuto K, Matsubara H. Volumetric histogram analysis of apparent diffusion coefficient for predicting pathological complete response and survival in esophageal cancer patients treated with chemoradiotherapy. Am J Surg 2020;219:1024-9. [PMID: 31387687 DOI: 10.1016/j.amjsurg.2019.07.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
152 Bertero L, Massa F, Metovic J, Zanetti R, Castellano I, Ricardi U, Papotti M, Cassoni P. Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why? Virchows Arch 2018;472:519-31. [PMID: 29209757 DOI: 10.1007/s00428-017-2276-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
153 Hansen T, Nilsson M, Lindholm D, Sundström J, Hedberg J. Normal radiological lymph node appearance in the thorax. Dis Esophagus 2019;32:1-6. [PMID: 30561570 DOI: 10.1093/dote/doy120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Takeda FR, Tustumi F, Nigro BC, Sallum RAA, Ribeiro-Junior U, Cecconello I. TRANSHIATAL ESOPHAGECTOMY IS NOT ASSOCIATED WITH POOR QUALITY LYMPHADENECTOMY. Arq Bras Cir Dig 2019;32:e1475. [PMID: 31859928 DOI: 10.1590/0102-672020190001e1475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
155 Betancourt-Cuellar SL, Palacio DP, Benveniste MFK, Mawlawi Y, Erasmus JJ. Pitfalls and Pearls in Esophageal Carcinoma. Semin Ultrasound CT MR 2021;42:535-41. [PMID: 34895609 DOI: 10.1053/j.sult.2021.04.016] [Reference Citation Analysis]
156 Rahman SA, Walker RC, Lloyd MA, Grace BL, van Boxel GI, Kingma BF, Ruurda JP, van Hillegersberg R, Harris S, Parsons S, Mercer S, Griffiths EA, O'Neill JR, Turkington R, Fitzgerald RC, Underwood TJ; OCCAMS Consortium. Machine learning to predict early recurrence after oesophageal cancer surgery. Br J Surg 2020;107:1042-52. [PMID: 31997313 DOI: 10.1002/bjs.11461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
157 Kamarajah SK, Navidi M, Wahed S, Immanuel A, Hayes N, Griffin SM, Phillips AW. Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction. Ann Surg Oncol 2020;27:3182-92. [PMID: 32201923 DOI: 10.1245/s10434-020-08358-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Tan X, Ma Z, Yan L, Ye W, Liu Z, Liang C. Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma. Eur Radiol. 2019;29:392-400. [PMID: 29922924 DOI: 10.1007/s00330-018-5581-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
159 Coffey MR, Bachman KC, Worrell SG, Argote-Greene LM, Linden PA, Towe CW. Palliative Surgery Outcomes for Patients with Esophageal Cancer: An NCDB Analysis. J Surg Res 2021;267:229-34. [PMID: 34161839 DOI: 10.1016/j.jss.2021.05.013] [Reference Citation Analysis]
160 Oesophago-Gastric Anastomosis Study Group on behalf of the West Midlands Research Collaborative. Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA). BJS Open 2021;5:zrab010. [PMID: 34021328 DOI: 10.1093/bjsopen/zrab010] [Reference Citation Analysis]
161 Schmidlin EJ, Gill RR. New frontiers in esophageal radiology. Ann Transl Med 2021;9:904. [PMID: 34164538 DOI: 10.21037/atm-20-2909] [Reference Citation Analysis]
162 Diaz LI, Mony S, Klapman J. Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer. Ann Transl Med 2020;8:1106. [PMID: 33145325 DOI: 10.21037/atm-20-4143] [Reference Citation Analysis]
163 Zhang X, Yang J, Huang Q, Lyu J. Prognostic factors in patients with gastric adenocarcinoma using competing-risk analysis: a study of cases in the SEER database.Scand J Gastroenterol. 2019;54:1015-1021. [PMID: 31382800 DOI: 10.1080/00365521.2019.1649456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
164 Kaneko Y, Hisakura K, Ogawa K, Akashi Y, Ohara Y, Owada Y, Enomoto T, Furuya K, Moue S, Doi M, Takahashi K, Shimomura O, Hashimoto S, Sakamoto N, Maruyama T, Oda T. Long-term survival after esophagectomy with distal pancreatectomy for locally advanced esophageal cancer with pancreatic invasion: a case report. Surg Case Rep 2021;7:254. [PMID: 34905130 DOI: 10.1186/s40792-021-01338-w] [Reference Citation Analysis]
165 Chen H, Zhou X, Tang X, Li S, Zhang G. Prediction of Lymph Node Metastasis in Superficial Esophageal Cancer Using a Pattern Recognition Neural Network. Cancer Manag Res 2020;12:12249-58. [PMID: 33273861 DOI: 10.2147/CMAR.S270316] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Escrig Sos J, Gómez Quiles L, Maiocchi K. The 8th edition of the AJCC-TNM classification: New contributions to the staging of esophagogastric junction cancer. Cir Esp (Engl Ed) 2019;97:432-7. [PMID: 31029372 DOI: 10.1016/j.ciresp.2019.03.006] [Reference Citation Analysis]
167 Iwasaki K, Ota Y, Yamada E, Takahashi K, Watanabe T, Makuuchi Y, Suda T, Osaka Y, Seshimo A, Katsumata K, Tsuchida A. Primary malignant melanoma of the esophagus with multiple lymph node metastases: A case report and literature review. Medicine (Baltimore) 2020;99:e18573. [PMID: 32481357 DOI: 10.1097/MD.0000000000018573] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Park JS, Van der Wall H, Kennedy CW, Falk GL. Does age affect oesophagectomy survival: a cohort study. ANZ J Surg 2021;91:E14-9. [PMID: 33369846 DOI: 10.1111/ans.16519] [Reference Citation Analysis]
169 Rocha-Filho DR, Peixoto RD, Weschenfelder RF, Rego JFM, Riechelmann R, Coutinho AK, Fernandes GS, Jacome AA, Andrade AC, Murad AM, Mello CAL, Miguel DSCG, Gomes DBD, Racy DJ, Moraes ED, Akaishi EH, Carvalho ES, Mello ES, Filho FM, Coimbra FJF, Capareli FC, Arruda FF, Vieira FMAC, Takeda FR, Cotti GCC, Pereira GLS, Paulo GA, Ribeiro HSC, Lourenco LG, Crosara M, Toneto MG, Oliveira MB, de Lourdes Oliveira M, Begnami MD, Forones NM, Yagi O, Ashton-Prolla P, Aguillar PB, Amaral PCG, Hoff PM, Araujo RLC, Di Paula Filho RP, Gansl RC, Gil RA, Pfiffer TEF, Souza T, Ribeiro U Jr, Jesus VHF, Costa WL Jr, Prolla G. Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of oesophageal cancer. Ecancermedicalscience 2021;15:1195. [PMID: 33889204 DOI: 10.3332/ecancer.2021.1195] [Reference Citation Analysis]
170 Choi J, Chung H, Lee A, Kim JL, Cho SJ, Kim SG. Role of Endoscopic Ultrasound in Selecting Superficial Esophageal Cancers for Endoscopic Resection. Ann Thorac Surg 2021;111:1689-95. [PMID: 32980323 DOI: 10.1016/j.athoracsur.2020.07.029] [Reference Citation Analysis]
171 Aho J, Reisenauer J. Additional Patient Factors may Predict Survival in Esophageal Cancer Better than TMN Alone After Esophagectomy. Ann Surg Oncol 2019;26:3423-4. [PMID: 31399815 DOI: 10.1245/s10434-019-07527-0] [Reference Citation Analysis]
172 Chen YL, Li R, Chen TW, Ou J, Zhang XM, Chen F, Wu L, Jiang Y, Laws M, Shah K, Joseph B, Hu J. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis. Eur J Radiol 2019;112:112-20. [PMID: 30777199 DOI: 10.1016/j.ejrad.2019.01.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
173 Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours. World J Gastroenterol 2018; 24(13): 1429-1439 [PMID: 29632424 DOI: 10.3748/wjg.v24.i13.1429] [Reference Citation Analysis]
174 Hsu PK, Chen HS, Liu CC, Wu SC. Application of the Eighth AJCC TNM Staging System in Patients With Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 2018;105:1516-22. [PMID: 29409986 DOI: 10.1016/j.athoracsur.2017.12.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
175 Fan M, Dai L, Yan W, Yang Y, Lin Y, Chen K. Efficacy of programmed cell death protein 1 inhibitor in resection transformation treatment of esophageal cancer. Thorac Cancer 2021;12:2182-8. [PMID: 34137505 DOI: 10.1111/1759-7714.14054] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
176 Molina JC, Goudie E, Pollock C, Menezes V, Ferraro P, Lafontaine E, Martin J, Nasir B, Liberman M. Balloon Dilation for Endosonographic Staging in Esophageal Cancer: A Phase 1 Clinical Trial. Ann Thorac Surg 2021;111:1150-5. [PMID: 32866480 DOI: 10.1016/j.athoracsur.2020.06.063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
177 Park CH, Yang DH, Kim JW, Kim JH, Kim JH, Min YW, Lee SH, Bae JH, Chung H, Choi KD, Park JC, Lee H, Kwak MS, Kim B, Lee HJ, Lee HS, Choi M, Park DA, Lee JY, Byeon JS, Park CG, Cho JY, Lee ST, Chun HJ. [Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer]. Korean J Gastroenterol 2020;75:264-91. [PMID: 32448858 DOI: 10.4166/kjg.2020.75.5.264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Nevo Y, Calderone A, Kammili A, Boulila C, Renaud S, Cools-Lartigue J, Spicer J, Mueller C, Ferri L. Endoscopic pyloromyotomy in minimally invasive esophagectomy: a novel approach. Surg Endosc 2021. [PMID: 33948713 DOI: 10.1007/s00464-021-08511-0] [Reference Citation Analysis]
179 Elsherif SB, Andreou S, Virarkar M, Soule E, Gopireddy DR, Bhosale PR, Lall C. Role of precision imaging in esophageal cancer.J Thorac Dis. 2020;12:5159-5176. [PMID: 33145093 DOI: 10.21037/jtd.2019.08.15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
180 Fountoulakis A, Souglakos J, Vini L, Douridas GN, Koumarianou A, Kountourakis P, Agalianos C, Alexandrou A, Dervenis C, Gourtsoyianni S, Gouvas N, Kalogeridi M, Levidou G, Liakakos T, Sgouros J, Sgouros SN, Triantopoulou C, Xynos E. Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer. Updates Surg 2019;71:599-624. [DOI: 10.1007/s13304-019-00696-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
181 Heger P, Blank S, Gooßen K, Nienhüser H, Diener MK, Ulrich A, Mihaljevic AL, Schmidt T. Thoracoabdominal versus transhiatal surgical approaches for adenocarcinoma of the esophagogastric junction-a systematic review and meta-analysis. Langenbecks Arch Surg 2019;404:103-13. [PMID: 30607534 DOI: 10.1007/s00423-018-1745-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
182 Park CH, Yang DH, Kim JW, Kim JH, Min YW, Lee SH, Bae JH, Chung H, Choi KD, Park JC, Lee H, Kwak MS, Kim B, Lee HJ, Lee HS, Choi M, Park DA, Lee JY, Byeon JS, Park CG, Cho JY, Lee ST, Chun HJ. Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer.Clin Endosc. 2020;53:142-166. [PMID: 32252507 DOI: 10.5946/ce.2020.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
183 Lim CH, Park YJ, Shin M, Cho YS, Choi JY, Lee KH, Hyun SH. Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma. Clin Nucl Med 2020;45:e128-33. [PMID: 31977480 DOI: 10.1097/RLU.0000000000002926] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
184 Faiz Z, Huijgen LJW, Alqethami HJ, Burgerhof JGM, Kats-Ugurlu G, Plukker JTM. Prevalence and Prognostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer. Ann Surg Oncol 2018;25:1588-97. [PMID: 29611027 DOI: 10.1245/s10434-018-6448-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]